Frazier Healthcare VII
Frazier Healthcare Partners, founded in 1991 and based in Seattle, Washington, is a prominent private equity firm focused on providing growth capital to healthcare companies. With over $2 billion in assets under management, the firm has invested in more than 170 companies across various healthcare sectors, including healthcare services, pharmaceuticals, biotechnology, medical products, and life sciences. Frazier Healthcare Partners employs an active investment strategy, leveraging its team's extensive industry knowledge and network of healthcare executives to support the development of its portfolio companies. The firm aims to address unmet medical needs through innovation, particularly in therapeutics and related areas, while also focusing on profitable companies within healthcare services and related sectors across North America and Europe.
SanReno Therapeutics
Funding Round in 2021
SanReno Therapeutics specializes in the development, manufacturing, and commercialization of therapies for kidney diseases in several regions including the People's Republic of China, Hong Kong, Macau, Taiwan, and Singapore. Established through a joint venture involving Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, the company is dedicated to researching and producing innovative biotech solutions aimed at improving the quality of life for patients suffering from kidney-related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.